Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

País de afiliação
Intervalo de ano de publicação
1.
Exp Cell Res ; 375(2): 1-9, 2019 02 15.
Artigo em Inglês | MEDLINE | ID: mdl-30641040

RESUMO

We performed liquid chromatography-tandem mass spectrometry (LC-MS/MS) on control and TGF-ß1-exposed rat lung fibroblasts to identify proteins differentially expressed between cell populations. A total of 196 proteins were found to be differentially expressed in response to TGF-ß1 treatment. Guided by these results, we next determined whether similar changes in protein expression were detectable in the rat lung after chronic exposure to silica dust. Of the five proteins selected for further analysis, we found that levels of all proteins were markedly increased in the silica-exposed rat lung, including the proteins for the very low density lipoprotein receptor (VLDLR) and the transmembrane (type I) heparin sulfate proteoglycan called syndecan 2 (SDC2). Because VLDLR and SDC2 have not, to our knowledge, been previously linked to the pathobiology of silicosis, we next examined whether knockdown of either gene altered responses to TGF-ß1 in MRC-5 lung fibroblasts. Interestingly, we found knockdown of either VLDLR or SDC2 dramatically reduced collagen production to TGF-ß1, suggesting that both proteins might play a novel role in myofibroblast biology and pathogenesis of silica-induced pulmonary fibrosis. In summary, our findings suggest that performing LC-MS/MS on TGF-ß1 stimulated lung fibroblasts can uncover novel molecular targets of activated myofibroblasts in silica-exposed lung.


Assuntos
Fibroblastos/metabolismo , Silicose/genética , Transcriptoma , Fator de Crescimento Transformador beta/farmacologia , Animais , Células Cultivadas , Colágeno/genética , Colágeno/metabolismo , Fibroblastos/efeitos dos fármacos , Masculino , Ratos , Ratos Wistar , Receptores de LDL/genética , Receptores de LDL/metabolismo , Silicose/metabolismo , Sindecana-2/genética , Sindecana-2/metabolismo
2.
Toxicol Appl Pharmacol ; 348: 117-122, 2018 06 01.
Artigo em Inglês | MEDLINE | ID: mdl-29680408

RESUMO

Silicosis is the most common occupational lung disease in China, and is associated with a variety of complications, many of which are poorly understood. For example, recent data indicate that silicosis associates with the development of osteopenia, and in some cases this bone loss is severe, meeting criteria for osteoporosis. Although many factors are likely to contribute to this relationship, including a sedentary lifestyle in patients with advanced silicotic lung disease, we hypothesized that silica might directly reduce bone mineral density. In the present study, six Wistar rats were exposed to silica for 24 weeks in order to induce pulmonary silicosis and examine the relationship to bone mineral density. As expected, all rats exposed to silica developed severe pulmonary fibrosis, as manifested by the formation of innumerable silicotic nodules and the deposition of large amounts of interstitial collagen. Moreover, micro-CT results showed that bone mineral density (BMD) was also significantly reduced in rats exposed to silica when compared control animals and this associated with a modest reduction in serum calcium and 25-hydroxyvitamin D levels. In addition, we found that decreased BMD was also linked to increased osteoclast activity as well as fibrosis-like changes, and to the deposition of silica within bone marrow. In summary, our findings support the hypothesis that silicosis reduces bone mineral density and provide support for ongoing investigations into the mechanisms causing osteopenia in silicosis patients.


Assuntos
Densidade Óssea , Fêmur/patologia , Pulmão/patologia , Osteoporose/induzido quimicamente , Fibrose Pulmonar/induzido quimicamente , Dióxido de Silício , Silicose/etiologia , Tíbia/patologia , Animais , Cálcio/sangue , Colágeno/metabolismo , Modelos Animais de Doenças , Fêmur/diagnóstico por imagem , Pulmão/metabolismo , Masculino , Osteoclastos/efeitos dos fármacos , Osteoclastos/metabolismo , Osteoclastos/patologia , Osteoporose/sangue , Osteoporose/diagnóstico por imagem , Osteoporose/patologia , Fibrose Pulmonar/metabolismo , Fibrose Pulmonar/patologia , Ratos Wistar , Medição de Risco , Índice de Gravidade de Doença , Silicose/metabolismo , Silicose/patologia , Tíbia/diagnóstico por imagem , Fatores de Tempo , Vitamina D/análogos & derivados , Vitamina D/sangue , Microtomografia por Raio-X
3.
London; s.n; 1997. 62 p.
Monografia em Português | Coleciona SUS (Brasil) | ID: biblio-932436
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA